Nuzenio

Tipranks Insmed

Tipranks Insmed news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 15:39:30 GMTMorgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $218 - Moomoo
Fri, 07 Aug 2026 09:22:31 GMTInsmed (INSM): Brinsupri Outperformance and Raised Sales Guidance Support Buy Rating - TipRanks
Thu, 06 Aug 2026 19:03:57 GMTInsmed reports Q2 EPS (6c) vs. ($1.70) last year - TipRanks
Thu, 06 Aug 2026 18:36:05 GMTMatt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story - TipRanks
Thu, 06 Aug 2026 13:08:36 GMTWhy Insmed’s Hot Drug Launch Isn’t Saving the Stock - TipRanks
Sun, 02 Aug 2026 09:53:01 GMTInsmed (IM8N) Q1 2023 Earnings Report - Results, Call & Slides - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Insmed.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.